Characterization of the effects of the vasopressin V2 receptor on sweating, fluid balance, and performance during exercise

Author:

Hew-Butler Tamara1,Hummel Jed1,Rider Brian C.1,Verbalis Joseph G.2

Affiliation:

1. Exercise Science Program, Oakland University, Rochester, Michigan; and

2. Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC

Abstract

A regulatory effect of arginine vasopressin (AVP) on sweat water conservation has been hypothesized but not definitively evaluated. AVP-mediated insertion of sweat and salivary gland aquaporin-5 (AQP5) water channels through activation of the vasopressin type 2 receptor (V2R) remains an attractive, yet unexplored, mechanism that could result in a more concentrated sweat with resultant decreased water loss. Ten runners participated in a double-blind randomized control treadmill trial under three separate pharmacological conditions: a placebo, V2R agonist (0.2 mg desmopressin), or V2R antagonist (30 mg tolvaptan). After a familiarization trial, runners ran for 60 min at 60% of peak speed followed by a performance trial to volitional exhaustion. Outcome variables were collected at three exercise time points: baseline, after the steady-state run, and after the performance run. Body weight losses were <2% across all three trials. Significant pharmacological condition effects were noted for urine osmolality [ F = 84.98; P < 0.0001] and urine sodium concentration ([Na+]) [ F = 38.9; P < 0.0001], which verified both pharmacological activation and inhibition of the V2R at the kidney collecting duct. Plasma osmolality and [Na+] demonstrated significant exercise ( F = 26.0 and F = 11.1; P < 0.0001) and condition ( F = 5.1 and F = 3.8; P < 0.05) effects (osmolality and [Na+], respectively). No significant exercise or condition effects were noted for either sweat or salivary [Na+]. Significant exercise effects were noted for plasma [AVP] ( F = 22.3; P < 0.0001), peak core temperature ( F = 103.3; P < 0.0001), percent body weight change ( F = 6.3; P = 0.02), plasma volume change ( F = 21.8; P < 0.0001), and thirst rating ( F = 78.2; P < 0.0001). Performance time was not altered between conditions ( P = 0.80). In summary, AVP acting at V2R does not appear to regulate water losses from body fluids other than renal excretion during exercise.

Publisher

American Physiological Society

Subject

Physiology (medical),Physiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3